TipRanks
Go Ultimate55% OFF

Zenas BioPharma, Inc. (ZBIO) Balance Sheet

Zenas BioPharma, Inc. Balance Sheet

Zenas BioPharma, Inc.'s total assets for Q2 2026 were $701.69M, a decrease of 6.15% from the previous quarter. ZBIO total liabilities were $454.59M for the fiscal quarter, a 10.38% an increase from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22
$ 383.64M$ 369.97M$ 68.18M$ 74.58M
$ 141.50M$ 57.51M$ 293.90M$ 266.87M
$ 242.14M$ 312.46M$ -225.72M$ -192.29M

Currency in USD

Zenas BioPharma, Inc. Debt to Assets

0150M300M450M0 %200 %400 %600 %LiabilitiesDebt to Assets2022202320242025AssetsLiabilitiesDebt to Assets